Status:
COMPLETED
Interest of Positive Expiratory Pressure (PEP) Delivery by EzPAP® After Cardiac Surgery in the Management of Postoperative Atelectasis
Lead Sponsor:
Nantes University Hospital
Conditions:
Pulmonary Atelectasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pulmonary atelectasis is a frequent respiratory postoperative complication in cardiac surgery. Classically, the treatment of these patients is based on manual chest physiotherapy. Our objective is to ...
Eligibility Criteria
Inclusion
- Patients admitted in ICU after cardiac surgery by sternotomy with cardiopulmonary bypass presenting a pulmonary atelectasis after extubation, diagnosed by chest X-ray in postoperative period (day1 to day 2).
- Patients over 18 years of age
- Informed patient
Exclusion
- Cardiac arrhythmia
- Hemodynamic instability (mean blood pressure \< 65 mmHg or \> 95 mmHg)
- Respiratory rate \> 35/min
- Undrained pneumothorax
- Predictable trachea intubation or emergent surgery
- Patient oral refusal
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02262182
Start Date
November 1 2014
End Date
September 1 2016
Last Update
September 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes Universitary Hospital
Saint-Herblain, France, 44805